Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Learn about essential user friendly features to look for in crypto exchanges. Optimize your trading experience with these insights.
19,699 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
The AI-fueled rally pushes major indices higher, yet a tightening macro backdrop and tougher oversight loom as the ma...
Alphabet unveiled a record $84.75B equity sale to fuel AI infrastructure. The move sent ripples through the stock mar...
SpaceX’s emergence as a top public company captures headlines, but sustainable value hinges on cash flow, strategy, a...
AI is becoming a central force in personal finance, from investing apps to retirement planning. This report breaks do...
The White House announced a renewed naval blockade of Iranian shipping through the Strait of Hormuz and a 20% toll on...
As investors hunt for catalysts in 2026, the idea of a blockbuster stock split from Booking Holdings stands out. This...
Bank of America projects a future where humanoid robots outnumber cars by 2060, with two-thirds living in households....
New neuroscience findings link AI-assisted homework to a sharp decline in student cognitive engagement, prompting pol...
Wells Fargo lowers Amazon's price target to $312 while keeping an Overweight rating, highlighting AWS as the core eng...
June opened with volatility as Nu Holdings faced a fresh downgrade and a leadership transition. This article breaks d...